Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Tax Provisions (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Tax Provisions for 3 consecutive years, with $14.3 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 1458.67% to $14.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.4 million through Dec 2025, up 1031.24% year-over-year, with the annual reading at $16.4 million for FY2025, 987.24% up from the prior year.
  • Tax Provisions hit $14.3 million in Q4 2025 for Immunocore Holdings, up from $500000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $14.3 million in Q4 2025 to a low of -$5.9 million in Q4 2023.
  • Historically, Tax Provisions has averaged $755083.3 across 3 years, with a median of $346500.0 in 2023.
  • Biggest five-year swings in Tax Provisions: crashed 1385.71% in 2024 and later surged 1458.67% in 2025.
  • Year by year, Tax Provisions stood at -$5.9 million in 2023, then surged by 82.24% to -$1.0 million in 2024, then soared by 1458.67% to $14.3 million in 2025.
  • Business Quant data shows Tax Provisions for IMCR at $14.3 million in Q4 2025, $500000.0 in Q3 2025, and $600000.0 in Q2 2025.